34 results
8-K
EX-1.1
AKRO
Akero Therapeutics Inc
6 Mar 24
Entry into a Material Definitive Agreement
5:25pm
be expected to have a Material Adverse Effect. “Hazardous Materials” means any material, chemical, substance, waste, pollutant, contaminant, compound
8-K
EX-1.1
cgrysg
17 May 23
Akero Therapeutics Announces Pricing of $220.0 Million Underwritten Offering of Common Stock
5:01pm
8-K
EX-1.1
yv18k 549o
16 Sep 22
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.1
32722o8jiz
16 Jun 22
Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million
7:14am
S-3ASR
EX-1.2
vkxos
18 May 21
Automatic shelf registration
6:01am